z-logo
open-access-imgOpen Access
Residual Plasma Viraemia and Infectious HIV-1 Recovery from Resting Memory CD4 Cells in Patients on Antiretroviral Therapy: Results from ACTG A5173
Author(s) -
Rajesh T. Gandhi,
Ronald J. Bosch,
Evgenia Aga,
Margaret A Bedison,
Barbara Bastow,
John L. Schmitz,
Janet D. Siliciano,
Robert F. Siliciano,
Joseph J. Eron,
John W. Mellors
Publication year - 2013
Publication title -
antiviral therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 87
eISSN - 2040-2058
pISSN - 1359-6535
DOI - 10.3851/imp2543
Subject(s) - cd38 , virology , biology , virus , viral load , cd8 , viremia , immunology , lentivirus , viral disease , simian immunodeficiency virus , antiretroviral therapy , sida , rna , immune system , biochemistry , genetics , stem cell , cd34 , gene
In HIV-1-infected patients receiving antiretroviral therapy (ART), the relationship between residual viraemia and ex vivo recovery of infectious virus from latently infected CD4 cells is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom